2021-05-10T15:01:38-05:00 2020-12-31 330783700 PDM LLP 3460 TORRANCE BLVD STE 200 TORRANCE CA 90503 990 2020-01-01 264712664 OPEN MEDICINE FOUNDATION INC OPEN 6502428669 29302 LARO DRIVE AGOURA HILLS CA 91301 LINDA TANNENBAUM CEO / PRESIDENT 6502428669 2021-05-10 1 LINDA TANNENBAUM 999009999 ANTHONY P BOZANIC CPA P01314417 3105404118 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z LINDA TANNENBAUM 29302 LARO DRIVE AGOURA HILLS CA 91301 4062970 0 X WWW.OMF.NGO X 2009 CA FUNDS MEDICAL RESEARCH TO FIND TREATMENTS AND DIAGNOSTIC MARKERS FOR CHRONIC COMPLEX DISEASES. 8 6 8 136 0 0 4253174 4049835 0 0 33439 9037 0 4098 4286613 4062970 2017269 3270049 0 0 523212 682316 0 0 378647 520450 407957 3060931 4360322 1225682 -297352 7489877 7627636 1290558 1725669 6199319 5901967 SUPPORTS COLLABORATIVE MEDICAL RESEARCH TO FIND EFFECTIVE TREATMENTS AND DIAGNOSTIC MARKERS FOR CHRONIC COMPLEX DISEASES (CURRENTLY FOCUSING ON MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME). 0 0 3791553 3270049 THE ORGANIZATION SUPPORTS COLLABORATIVE MEDICAL RESEARCH TO FIND EFFECTIVE TREATMENTS AND DIAGNOSTIC MARKERS FOR CHRONIC COMPLEX DISEASES. THROUGH THESE COLLABORATIVE MEDICAL RESEARCH EFFORTS, WE STRIVE TO FIND EFFECTIVE TREATMENTS FOR THOSE SUFFERING FROM DIFFICULT-TO-TREAT DISEASES, BY BRINGING TOGETHER A COMMUNITY OF THOUGHT LEADERS, PATIENTS, CLINICIANS AND RESEARCHERS FOR TARGETED INITIATIVES. WE ARE CURRENTLY FOCUSED ON RESEARCHING MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME IN HOPES OF DISCOVERING DIAGNOSTIC MARKERS AND TO BRING ANSWERS TO OTHER CHRONIC COMPLEX DISEASES THAT SHARE SIMILAR SYMPTOMS. 3791553 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 1 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 16 0 1 8 1 0 0 0 0 0 0 0 0 0 0 X 8 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA CO CT DC FL GA IL KY MA MD MI MS NC NH NJ NM OH OK OR PA RI SC TN UT VA WA WI WV X X JITASA GROUP 2082874777 1750 W FRONT STREET BOISE ID 83702 LINDA TANNENBAUM CEO / PRESIDENT 40.00 X X 182326 0 0 KIMBERLY HICKS TREASURER 20.00 X X 58333 0 0 PATTI LINSLEY SECRETARY 5.00 X X 0 0 0 KATIE BACH BOARD OF DIRECTORS 5.00 X 0 0 0 CAROL JENSEN BOARD OF DIRECTORS 5.00 X 0 0 0 SHAI HELD BOARD OF DIRECTORS 5.00 X 0 0 0 DEBORAH ROSE BOARD OF DIRECTORS 5.00 X 0 0 0 HANY ZAYED BOARD OF DIRECTORS 5.00 X 0 0 0 KATHLEEN MORGAN VP OF PHILANTHROPY 40.00 X 150000 0 0 CHRISTOPHER ARMSTRONG MEDICAL RESEARCHER 40.00 X 110000 0 0 500659 0 0 3 0 1 0 EFFECTIVE AND SUSTAINABLE ORGANIZATIONS 851 KATHY DIANNE DRIVE FORT MILL SC 29707 CONSULTING SERVICES 102625 1 4049835 4049835 9037 9037 OTHER REVENUE 900099 4098 4098 4098 4062970 0 0 13135 2572999 2572999 697050 697050 240659 168461 36099 36099 372607 115841 64550 192216 21258 9855 3489 7914 47792 22156 7843 17793 7999 6399 1600 37200 29760 7440 211447 129929 30767 50751 36127 18064 18063 15624 15624 62806 21039 12035 29732 3483 3483 3740 3740 FUNDRAISING 26079 26079 TAXES AND LICENSES 3452 3452 4360322 3791553 190122 378647 6823210 7294302 666667 333334 7489877 7627636 32435 67539 1258123 1567755 0 90375 1290558 1725669 X 2752611 3034300 3446708 2867667 6199319 5901967 7489877 7627636 -297352 0 X X 0 1 X 1 0 X 1627284 2656038 8903857 4253049 4049835 21490063 1627284 2656038 8903857 4253049 4049835 21490063 7414305 14075758 459 1069 4938 33439 9037 48942 125 4098 4223 21543228 0.65340 0.56300 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 CARES ACT FORGIVABLE LOAN PAYABLE 90375 90375 X 4754718 691748 691748 4062970 0 4062970 5530333 1170011 1170011 4360322 0 4360322 PART X, LINE 2: UNCERTAIN TAX POSITIONS FOOTNOTE PER AUDITED FINANCIAL STATEMENTS: IN ACCORDANCE WITH ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA, THE ORGANIZATION RECOGNIZES THE IMPACT OF TAX POSITIONS IN THE FINANCIAL STATEMENTS IF THAT POSITION IS MORE LIKELY THAN NOT OF BEING SUSTAINED IN AN AUDIT, BASED ON THE TECHNICAL MERITS OF THE POSITION. TO DATE, THE ORGANIZATION HAD NO TAX POSITIONS WHICH, IN THE OPINION OF MANAGEMENT, WILL BE REVERSED IF CHALLENGED BY A TAXING AUTHORITY. DURING THE YEAR, THE ORGANIZATION DID NOT RECOGNIZE ANY AMOUNT IN POTENTIAL INTEREST AND PENALTIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS. PART XI, LINE 2D: CONSOLIDATED INDEPENDENT AUDITED FINANCIAL STATEMENTS INCLUDES: THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY. BOTH THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY SHARE TWO BOARD MEMBERS AND THE DEPENDENCY ON THE FOUNDATION FOR ITS BACK OFFICE AND ADMINISTRATIVE FUNCTION. PART XII, LINE 2D: CONSOLIDATED INDEPENDENT AUDITED FINANCIAL STATEMENTS INCLUDES: THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY. BOTH THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY SHARE TWO BOARD MEMBERS AND THE DEPENDENCY ON THE FOUNDATION FOR ITS BACK OFFICE AND ADMINISTRATIVE FUNCTION. 1 EUROPE 1 PROGRAM SERVICES RESEARCH 652100 SUB-SAHARAN AFRICA 1 PROGRAM SERVICES PATIENT SERVICES AND AWARENESS 4950 CANADA 1 PROGRAM SERVICES COVID STUDIES 40000 0 3 0 0 0 3 697050 0 697050 NORTH AMERICA RESEARCH 40000 WIRE EUROPE RESEARCH 652100 WIRE SOUTH AFRICA RESEARCH 4950 WIRE 2 1 RESEARCH GRANTS EUROPE 652100 WIRE COVID STUDIES NORTH AMERICA 40000 WIRE PATIENT SERVICES & AWARENESS SUB-SAHARAN AFRICA 4950 WIRE 0 0 0 0 0 0 PART I, LINE 2: ALL GRANTEES REQUESTING RESEARCH FUNDING FROM THE ORGANIZATION MUST DO SO UNDER AN APPROVED GRANT. ALL GRANT PROPOSALS MUST BE APPROVED BY BOTH THE SCIENTIFIC ADVISORY BOARD EXECUTIVE COMMITTEE AND THE ORGANIZATION'S FULL FOUNDATION BOARD. ONCE THE GRANTS ARE APPROVED, GRANTEES ARE REQUIRED TO COMPLETE A GRANT REQUEST FORM ALONG WITH ALL RELEVANT DOCUMENTATION (PROJECT INFORMATION, PORTION OF GRANT COMMITMENT BEING REQUESTED, ETC). THE ORGANIZATION'S TREASURER WORKS WITH THE CEO, AND KEY CONTACTS AT THE GRANTEE'S INSTITUTION TO CONFIRM AND VALIDATE ALL GRANTEE INFORMATION. A PAYMENT SCHEDULE IS AGREED BY BOTH THE ORGANIZATION AND GRANTEE. FUNDS ARE THEN DISBURSED ALONG WITH THE ORIGINAL GRANT REQUEST FORM, AND A LETTER OR EMAIL FROM THE ORGANIZATION CONFIRMING THE INTENDED USE OF THE FUNDS, AND A REQUEST FOR LETTER/EMAIL CONFIRMING RECEIPT OF FUNDS. ALL GRANTEES ARE REQUIRED TO PROVIDE REGULAR UPDATES TO THE ORGANIZATION'S CEO ON PROJECT STATUS, AND THE ORGANIZATION'S TREASURER WORKS WITH KEY CONTACTS AT EACH RECIPIENT INSTITUTION TO RECEIVE FINANCIAL UPDATES. ALL GRANT PAYMENTS ARE LOGGED AND TRACKED BY THE TREASURER, AND RECONCILED ON A REGULAR, ONGOING BASIS. PART III ACCOUNTING METHOD: 1 BRIGHAM & WOMEN'S (DAVID SYSTROM) 75 FRANCIS STREET PBB CLINICS 3 BOSTON MA 02115 042312909 150000 HARVARD CRC - MESTINON TRIAL NATIONAL ANALYTICAL INSTRUMENTS 1525 FRANCISCO BLVD E SUITE 5 SAN RAFAEL CA 94901 680472295 38150 ME/CFS RESEARCH NOVOGENE COPORATION 8801 FOLSOM BLVD SUITE 290 SACRAMENTO CA 95826 000000000 27550 HARVARD CRC - ICPET STUDY PETERSEN SIERRA INTERNAL MEDICINE PO BOX 7870 INCLINE VILLAGE NV 89450 880403942 104060 ME/CFS RESEARCH STANFORD UNIVERSITY - CHEMICAL ENGINEERING DEPARTMENT 443 VIA ORTEGA SUITE 129 STANFORD CA 94305 941156365 501C3 30000 RED BLOOD CELL STUDIES STANFORD UNIVERSITY - MECHANICAL ENGINEERING DEPARTMENT 440 ESCONDIDO MALL STANFORD CA 94305 941156365 501C3 30000 RED BLOOD CELL STUDIES TOWER FOUNDATION OF SAN JOSE STATE UNIVERSITY ONE WASHINGTON SQUARE SAN JOSE CA 95192 830403915 501C3 35620 RED BLOOD CELL STUDIES TRUSTEES OF BOSTON UNIVERSITY (LEWIS KAZIS) 25 BUICK STREET BOSTON MA 021142621 042103547 275000 HARVARD CRC - PASS/CAT & REDCAP DEVELOPMENT MASS GENERAL HOSPITAL - RESEARCH FOR DR WENZHONG XIAO 555 FRUIT STREET BOSTON MA 021142621 042697983 250000 RESEARCH PLATFORM THE STANFORD CFS RESEARCH CENTER FOR DR RONALD DAVIS 3165 PORTER DRIVE PALO ALTO CA 943045503 941156365 501C3 1000000 STANFORD CRC 4 6 X X 0 0 0 0 0 0 0 0 0 LINDA TANNENBAUM CEO / PRESIDENT 182326 0 0 0 0 0 0 0 0 0 182326 0 0 0 KIMBERLY HICKS INTERIM CFO/COO 102625 CONSULTING SERVICE FEES PAID TO EFFECTIVE AND SUSTAINABLE ORGANIZATIONS INC DIRECTLY OWNED BY KIMBERLY HICKS, TREASURER 0 FORM 990, PART VI, SECTION B, LINE 11B THE CEO / PRESIDENT OBTAINS THE FINAL DRAFT OF THE FORM 990 FROM THE ORGANIZATON'S THIRD-PARTY 990 PREPARER AND REVIEWS. THE CEO/PRESIDENT THEN DISTRIBUTES THE COPIES OF THE FORM 990 FINAL DRAFT TO THE BOARD. THE BOARD WILL REVIEW AND APPROVE THE FINAL FORM 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY, DURING BOD ELECTIONS, MEMBERS ARE ASKED TO SIGN THE CONFLICT OF INTEREST POLICY CONFIRMING THAT THEY UNDERSTAND THE POLICY AND ARE IN CONFORMITY WITH THE POLICY. ALL NEW STAFF AND BOARD MEMBERS ARE INFORMED OF THE POLICY AND ASKED IF THEY HAVE ANY CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 ALL CHANGES IN MANAGEMENT COMPENSATION AND HIRING ARE APPROVED BY A VOTE OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THERE HAVE BEEN NO CHANGES IN OVERSIGHT OR THE SELECTION PROCESS DURING THE YEAR.